Breaking the Gut-Liver Axis: Breakthrough Experimental Drug Reverses Severe Fatty Liver Disease
Comments Off on Breaking the Gut-Liver Axis: Breakthrough Experimental Drug Reverses Severe Fatty Liver Disease
July 11, 2026
In a significant advancement for hepatology and metabolic medicine, researchers at Michigan Medicine have unveiled a promising new therapeutic strategy to combat metabolic dysfunction-associated steatohepatitis (MASH). A study published in The Journal of…
Revitalizing the Brain’s Defenses: The Experimental Molecule OLE Offers New Hope in Alzheimer’s Research
Comments Off on Revitalizing the Brain’s Defenses: The Experimental Molecule OLE Offers New Hope in Alzheimer’s Research
June 20, 2026
In a groundbreaking study that could fundamentally alter the landscape of neurodegenerative medicine, an international team of researchers has identified a promising experimental molecule capable of "reprogramming" the brain’s own immune system…
